Literature DB >> 10556556

Helix 6 of subdomain III A of human serum albumin is the region primarily photolabeled by ketoprofen, an arylpropionic acid NSAID containing a benzophenone moiety.

V T Chuang1, A Kuniyasu, H Nakayama, Y Matsushita, S Hirono, M Otagiri.   

Abstract

It is well known that the subdomain III A (site II) of human serum albumin (HSA) binds a variety of endogenous and exogenous substances. However, the nature of the microenvironment of the binding site remains unclear. Ketoprofen (KP), an arylpropionic acid NSAID which contains a benzophenone moiety, was used as a photoaffinity labeling agent to label the binding region. Subsequent CNBr cleavage of the photolabeled HSA revealed that the 11.6 kDa and 9.4 kDa fragments contained most of the incorporated radioactivity. Competition experiments showed that the 11.6 kDa fragment contains the common binding region for site II ligands. This fragment was redigested with Achromobacter lyticus protease I (AP-I) and the amino acid sequence of the photolabeled peptide was determined to be XCTESLVNRR, which corresponds to the sequence 476C-485K of HSA. The complete amino acid sequence of the corresponding AP-I digested HSA peptide encompasses residues 476 to 499, which form helices 5 and 6 of subdomain III A. The HSA-Myr X-ray crystallography data showed that helix 5 is involved to the least extent in ligand binding. A docking model provided further support that helix 6 represents the photolabeled region of KP.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556556     DOI: 10.1016/s0167-4838(99)00174-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Role of arg-410 and tyr-411 in human serum albumin for ligand binding and esterase-like activity.

Authors:  H Watanabe; S Tanase; K Nakajou; T Maruyama; U Kragh-Hansen; M Otagiri
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

2.  Effect of oxidative stress on the structure and function of human serum albumin.

Authors:  M Anraku; K Yamasaki; T Maruyama; U Kragh-Hansen; M Otagiri
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

3.  How do fatty acids cause allosteric binding of drugs to human serum albumin?

Authors:  Victor Tuan Giam Chuang; Masaki Otagiri
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

4.  Validation of the chloramine-T induced oxidation of human serum albumin as a model for oxidative damage in vivo.

Authors:  Makoto Anraku; Ulrich Kragh-Hansen; Keiichi Kawai; Toru Maruyama; Yasuomi Yamasaki; Yoshinobu Takakura; Masaki Otagiri
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

5.  Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury.

Authors:  Riccardo Bertini; Marcello Allegretti; Cinzia Bizzarri; Alessio Moriconi; Massimo Locati; Giuseppe Zampella; Maria N Cervellera; Vito Di Cioccio; Maria C Cesta; Emanuela Galliera; Fernando O Martinez; Rosa Di Bitondo; Giulia Troiani; Vilma Sabbatini; Gaetano D'Anniballe; Roberto Anacardio; Juan C Cutrin; Barbara Cavalieri; Fabrizio Mainiero; Raffaele Strippoli; Pia Villa; Maria Di Girolamo; Franck Martin; Marco Gentile; Angela Santoni; Daniela Corda; Giuseppe Poli; Alberto Mantovani; Pietro Ghezzi; Francesco Colotta
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-28       Impact factor: 11.205

6.  Interaction of human serum album and C₆₀ aggregates in solution.

Authors:  Maoyong Song; Shufang Liu; Junfa Yin; Hailin Wang
Journal:  Int J Mol Sci       Date:  2011-08-04       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.